Olanzapine embonate 405mg powder and solvent for prolonged-release suspension for injection vials

in short Olanzapine embonate 405mg pdr and solvent for PR inj

previously Olanzapine embonate 405mg powder and solvent for suspension for injection vials

SNOMED code
17038711000001107
Named
Active compound
Olanzapine embonate
Preferred name basis
INNM - International Non-proprietary Name (Modified)
previously
INNM - International Non-proprietary Name (Modified)
Prescribable
✅ Yes
Dose form
Discrete
Dose size and units
1 vial, vial
Ingredients
Olanzapine embonate monohydrate, ID: 386849001 — 405 mg based on base substance
Form & Route
suspensioninjectionprolonged-release.intramuscular-deep
Powder and solvent for prolonged-release suspension for inj, Intramuscular
Controlled drug
No Controlled Drug Status

Products

Zypadhera 405mg powder and solvent for prolonged-release suspension for injection vials (Neon Healthcare Ltd)

in short Zypadhera 405mg pdr and solvent for prolonged-rel inj vials

previously Zypadhera 405mg powder and solvent for suspension for injection vials

Zypadhera 405mg powder and solvent for prolonged-release suspension for injection vials

SNOMED code
17039011000001100
Named
Supplier
Neon Healthcare Ltd
Licensed as
Medicines - MHRA/EMA
Availability restrictions
None
Licensed route
Intramuscular
Pack name & codeStatusGTIN, EAN barcodesPricePrescribingReimbursementPack
Zypadhera 405mg powder and solvent for prolonged-release suspension for injection vials (Neon Healthcare Ltd) 1 vial
17039111000001104   ref. pack
💯 Available

Legal category: POM
5014602101398

End: 5060499391572
NHS Indicative Price
£285.52
• Personally Administered
  • • Prescription Charges
  • • Dispensing Fees
  • • Special container

Reference packs

Olanzapine embonate 405mg powder and solvent for prolonged-release suspension for injection vials 1 vial
SNOMED code
17038811000001104
Quantity and unit
1 vial
Packs